Billets de Michelle Dawson

Billet publié sur Twitter/X le 09/10/2023 10:31

Twitter/X Essai clinique clinicaltrials.gov Extrait cité dans le billet Question posée par Dawson dans le billet Lien intégré au billet Termes sur l’autisme

Liens cités structurés

1 ressource citée

Essai clinique Récupéré Publication clinicaltrials.gov

Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (2024). DINO RCT - Treating Anxiety in Children With Autism. ClinicalTrials.gov. Hugo W. Moser Research Institute at Kennedy Krieger, Inc..

Date de publication
02/01/2024
Identifiant
NCT06066983
Auteurs
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Source
ClinicalTrials.gov
Type de référence
clinical_trial
Éditeur
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Source de métadonnées
clinicaltrials.gov

Résumé

Anxiety is prevalent in young children, under 7 years of age, with autism. Yet, few studies have examined anxiety interventions for this age range, and only one anxiety treatment study has included young children with cognitive and language delays. Anxiety treatment models utilizing cognitive-behavioral therapy (CBT), adapted for children with autism, are empirically supported in school-age autistic children. Further, preliminary evidence suggests CBT approaches may reduce intolerance of uncertainty (IU), a mechanistic construct that may contribute to the maintenance of anxiety in autistic children. This study seeks to address the existing gap in anxiety treatment by examining the feasibility and preliminary efficacy of a novel, telehealth CBT intervention, DINO Strategies for Anxiety and intolerance of Uncertainty Reduction (DINOSAUR), which targets both anxiety and IU in young autistic children.